Neogen Common Stock Shares Outstanding vs Total Current Liabilities Analysis
| NEOG Stock | USD 13.54 0.13 0.97% |
Neogen financial indicator trend analysis is infinitely more than just investigating Neogen recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Neogen is a good investment. Please check the relationship between Neogen Common Stock Shares Outstanding and its Total Current Liabilities accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Neogen. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. For more detail on how to invest in Neogen Stock please use our How to Invest in Neogen guide.
Common Stock Shares Outstanding vs Total Current Liabilities
Common Stock Shares Outstanding vs Total Current Liabilities Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Neogen Common Stock Shares Outstanding account and Total Current Liabilities. At this time, the significance of the direction appears to have almost identical trend.
The correlation between Neogen's Common Stock Shares Outstanding and Total Current Liabilities is 0.95. Overlapping area represents the amount of variation of Common Stock Shares Outstanding that can explain the historical movement of Total Current Liabilities in the same time period over historical financial statements of Neogen, assuming nothing else is changed. The correlation between historical values of Neogen's Common Stock Shares Outstanding and Total Current Liabilities is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Common Stock Shares Outstanding of Neogen are associated (or correlated) with its Total Current Liabilities. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Current Liabilities has no effect on the direction of Common Stock Shares Outstanding i.e., Neogen's Common Stock Shares Outstanding and Total Current Liabilities go up and down completely randomly.
Correlation Coefficient | 0.95 |
| Relationship Direction | Positive |
| Relationship Strength | Very Strong |
Common Stock Shares Outstanding
The total number of shares of a company's common stock that are currently owned by all its shareholders.Total Current Liabilities
Total Current Liabilities is an item on Neogen balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Neogen are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Most indicators from Neogen's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Neogen current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Neogen. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. For more detail on how to invest in Neogen Stock please use our How to Invest in Neogen guide.At this time, Neogen's Enterprise Value Multiple is most likely to increase significantly in the upcoming years. The Neogen's current Enterprise Value is estimated to increase to about 3.8 B, while Tax Provision is projected to decrease to roughly 707.9 K.
| 2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 243.0M | 406.0M | 466.8M | 490.2M | Total Revenue | 527.2M | 822.4M | 945.8M | 993.1M |
Neogen fundamental ratios Correlations
Click cells to compare fundamentals
Neogen Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Neogen fundamental ratios Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Assets | 797.2M | 920.2M | 992.9M | 4.6B | 5.2B | 5.5B | |
| Other Current Liab | 22.8M | 25.0M | 36.3M | 60.9M | 70.0M | 73.5M | |
| Total Current Liabilities | 48.5M | 53.6M | 77.8M | 145.5M | 167.3M | 175.7M | |
| Total Stockholder Equity | 725.2M | 840.4M | 887.4M | 3.1B | 3.6B | 3.8B | |
| Property Plant And Equipment Net | 78.7M | 100.5M | 110.6M | 198.7M | 228.6M | 240.0M | |
| Net Debt | (342.6M) | (379.8M) | 605.6M | 736.8M | 663.1M | 696.2M | |
| Retained Earnings | 478.7M | 539.6M | 587.9M | 565.0M | 649.8M | 682.3M | |
| Cash | 343.7M | 381.1M | 381.1M | 163.2M | 187.7M | 197.1M | |
| Non Current Assets Total | 259.8M | 328.7M | 366.1M | 4.0B | 4.6B | 4.8B | |
| Non Currrent Assets Other | 2.2M | 2.0M | 2.2M | 15.2M | 17.5M | 15.5M | |
| Cash And Short Term Investments | 343.7M | 381.1M | 381.1M | 245.6M | 282.4M | 296.5M | |
| Net Receivables | 84.7M | 91.8M | 99.7M | 153.3M | 176.2M | 185.1M | |
| Common Stock Shares Outstanding | 105.7M | 107.1M | 108.0M | 188.9M | 217.2M | 228.1M | |
| Liabilities And Stockholders Equity | 797.2M | 920.2M | 992.9M | 4.6B | 5.2B | 5.5B | |
| Non Current Liabilities Total | 23.5M | 26.2M | 27.7M | 1.3B | 1.5B | 1.5B | |
| Inventory | 95.1M | 100.7M | 122.3M | 133.8M | 153.9M | 161.6M | |
| Other Current Assets | 14.0M | 17.8M | 23.8M | 53.3M | 61.3M | 64.4M | |
| Other Stockholder Equity | 257.7M | 295.0M | 310.0M | 2.6B | 3.0B | 3.1B | |
| Total Liab | 72.0M | 79.8M | 105.6M | 1.4B | 1.6B | 1.7B | |
| Property Plant And Equipment Gross | 80.6M | 102.9M | 215.5M | 318.9M | 366.7M | 385.0M | |
| Total Current Assets | 537.4M | 591.5M | 626.8M | 585.9M | 673.8M | 707.5M | |
| Accumulated Other Comprehensive Income | (19.7M) | (11.4M) | (27.8M) | (33.3M) | (29.9M) | (28.4M) | |
| Intangible Assets | 66.6M | 92.3M | 107.5M | 1.6B | 1.8B | 1.9B | |
| Accounts Payable | 25.7M | 23.9M | 34.6M | 76.7M | 88.2M | 92.6M | |
| Common Stock Total Equity | 8.5M | 17.2M | 17.2M | 34.6M | 39.8M | 41.8M | |
| Short Term Investments | 277.4M | 305.5M | 336.6M | 82.3M | 94.7M | 91.9M | |
| Common Stock | 8.5M | 17.2M | 17.2M | 34.6M | 39.8M | 37.8M | |
| Other Liab | 22.6M | 26.2M | 27.7M | 375.7M | 432.1M | 453.7M | |
| Other Assets | 2.2M | 2.0M | 4.8B | 15.2M | 17.5M | 16.6M | |
| Good Will | 181.1M | 228.3M | 255.5M | 3.8B | 4.3B | 4.6B | |
| Property Plant Equipment | 78.7M | 100.5M | 110.6M | 198.7M | 228.6M | 240.0M | |
| Net Tangible Assets | 599.6M | 612.1M | 887.4M | 3.1B | 3.6B | 3.8B | |
| Retained Earnings Total Equity | 478.7M | 539.6M | 587.9M | 565.0M | 649.8M | 382.8M |
Currently Active Assets on Macroaxis
When determining whether Neogen is a strong investment it is important to analyze Neogen's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Neogen's future performance. For an informed investment choice regarding Neogen Stock, refer to the following important reports:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Neogen. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. For more detail on how to invest in Neogen Stock please use our How to Invest in Neogen guide.You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Complementary Tools for Neogen Stock analysis
When running Neogen's price analysis, check to measure Neogen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neogen is operating at the current time. Most of Neogen's value examination focuses on studying past and present price action to predict the probability of Neogen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neogen's price. Additionally, you may evaluate how the addition of Neogen to your portfolios can decrease your overall portfolio volatility.
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |
Is Neogen's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Neogen. If investors know Neogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Neogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.86) | Earnings Share 0.02 | Revenue Per Share 4.293 | Quarterly Revenue Growth 0.048 | Return On Assets 0.0179 |
The market value of Neogen is measured differently than its book value, which is the value of Neogen that is recorded on the company's balance sheet. Investors also form their own opinion of Neogen's value that differs from its market value or its book value, called intrinsic value, which is Neogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Neogen's market value can be influenced by many factors that don't directly affect Neogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Neogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Neogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Neogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.